Polymorph form of (r)-2-[2-amino-3-(indol-3-yl)propionylamino]-2- methylpropionic acid… Grant US-11891455-B2 United States of America 06 Feb 2024
METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDER Application WO-2023214189-A1 World Intellectual Property Organisation (WIPO) 09 Nov 2023
Nanoscale process to generate reagents selective for individual protein variants Grant US-RE49625-E1 United States of America 29 Aug 2023
Isoindoline compositions and methods for treating neurodegenerative disease Grant US-11691947-B2 United States of America 04 Jul 2023
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE Application EP-4023294-A1 European Patent Office 06 Jul 2022
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers Grant US-11319348-B2 United States of America 03 May 2022
Compositions for treating neurodegenerative diseases Grant US-11214540-B2 United States of America 04 Jan 2022
GENETICALLY ENGINEERED PHAGOCYTES, AND RELATED COMPOSITIONS, VECTORS, METHODS AND SYSTEMS Application WO-2021217087-A1 World Intellectual Property Organisation (WIPO) 28 Oct 2021
DETECTION OF A-BETA OLIGOMERS Application WO-2021032966-A1 World Intellectual Property Organisation (WIPO) 25 Feb 2021
Combinational fendiline formulations and uses thereof Grant US-10772847-B1 United States of America 15 Sep 2020
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers Grant US-10662226-B2 United States of America 26 May 2020
Isoindoline compositions and methods for treating neurodegenerative disease Grant US-10611728-B2 United States of America 07 Apr 2020
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE Application EP-3498692-A1 European Patent Office 19 Jun 2019
Isoindoline compositions and methods for treating neurodegenerative disease Grant US-10207991-B2 United States of America 19 Feb 2019
Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases Grant US-10100308-B2 United States of America 16 Oct 2018
Nanoscale process to generate reagents selective for individual protein variants Grant US-9938330-B2 United States of America 10 Apr 2018
Oligomer-specific amyloid beta epitope and antibodies Application US-9849165-B2 United States of America 26 Dec 2017
Isoindoline compositions and methods for treating neurodegenerative disease Grant US-9796672-B2 United States of America 24 Oct 2017
Compositions and methods related to tauopathy Grant US-9605042-B2 United States of America 28 Mar 2017
Isolated compounds from turmeric oil and methods of use Grant US-9499462-B2 United States of America 22 Nov 2016
OLIGOMER-SPECIFIC AMYLOID BETA EPITOPE AND ANTIBODIES Application EP-3056510-A1 European Patent Office 17 Aug 2016
Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases Grant US-9388414-B2 United States of America 12 Jul 2016
Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases Grant US-9388413-B2 United States of America 12 Jul 2016
COMPOSITIONS FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES Application EP-3026057-A2 European Patent Office 01 Jun 2016
Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of… Grant US-9272993-B2 United States of America 01 Mar 2016
Prion protein as a receptor for amyloid-β oligomers Application US-9217036-B2 United States of America 22 Dec 2015
ADDL receptor polypeptides, polynucleotides and host cells for recombinant production Grant US-9217024-B2 United States of America 22 Dec 2015
Oligomer-specific amyloid beta epitope and antibodies Application US-9216217-B2 United States of America 22 Dec 2015
Compositions and methods related to tauopathy Grant US-9200068-B2 United States of America 01 Dec 2015
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE Application WO-2015116923-A1 World Intellectual Property Organisation (WIPO) 06 Aug 2015
Antibodies that specifically bind to abeta oligomers and uses thereof Grant US-9090680-B2 United States of America 28 Jul 2015
Antibodies that specifically bind to A beta oligomers and use thereof Grant US-9090679-B2 United States of America 28 Jul 2015
Antibodies that specifically bind to Aβ oligomers and uses thereof Grant US-9085614-B2 United States of America 21 Jul 2015
Antibodies that specifically bind to a beta oligomers and use thereof Grant US-8858949-B2 United States of America 14 Oct 2014
Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of… Grant US-8697680-B2 United States of America 15 Apr 2014
Antibodies that specifically bind to A beta oligomers and use thereof Grant US-8613924-B2 United States of America 24 Dec 2013
Antibodies that specifically bind to Aβ oligomers and uses thereof Application US-8378081-B2 United States of America 19 Feb 2013
ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE Application WO-2012106426-A1 World Intellectual Property Organisation (WIPO) 09 Aug 2012
METHODS OF TREATING DIABETES AND COMPOSITIONS CAPABLE OF SAME Application WO-2011151833-A1 World Intellectual Property Organisation (WIPO) 08 Dec 2011
COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES Application WO-2010103515-A2 World Intellectual Property Organisation (WIPO) 16 Sep 2010
MEANS AND METHODS FOR THE PRODUCTION OF AMYLOID OLIGOMERS Application WO-2008028939-A1 World Intellectual Property Organisation (WIPO) 13 Mar 2008